Advisorshares Psychedelics Etf Performance
| PSIL Etf | USD 16.92 0.28 1.63% |
The etf shows a Beta (market volatility) of 1.74, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, AdvisorShares Psychedelics will likely underperform.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days AdvisorShares Psychedelics ETF has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Etf's forward indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the ETF venture institutional investors. ...more
1 | Best-Performing Active ETFs of 2025 | 12/31/2025 |
AdvisorShares | Build AI portfolio with AdvisorShares Etf |
AdvisorShares Psychedelics Relative Risk vs. Return Landscape
If you would invest 1,862 in AdvisorShares Psychedelics ETF on October 8, 2025 and sell it today you would lose (170.00) from holding AdvisorShares Psychedelics ETF or give up 9.13% of portfolio value over 90 days. AdvisorShares Psychedelics ETF is currently does not generate positive expected returns and assumes 2.8155% risk (volatility on return distribution) over the 90 days horizon. In different words, 25% of etfs are less volatile than AdvisorShares, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
AdvisorShares Psychedelics Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for AdvisorShares Psychedelics' investment risk. Standard deviation is the most common way to measure market volatility of etfs, such as AdvisorShares Psychedelics ETF, and traders can use it to determine the average amount a AdvisorShares Psychedelics' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0417
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PSIL |
Based on monthly moving average AdvisorShares Psychedelics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of AdvisorShares Psychedelics by adding AdvisorShares Psychedelics to a well-diversified portfolio.
AdvisorShares Psychedelics Fundamentals Growth
AdvisorShares Etf prices reflect investors' perceptions of the future prospects and financial health of AdvisorShares Psychedelics, and AdvisorShares Psychedelics fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on AdvisorShares Etf performance.
| Total Asset | 7.74 M | |||
About AdvisorShares Psychedelics Performance
By examining AdvisorShares Psychedelics' fundamental ratios, stakeholders can obtain critical insights into AdvisorShares Psychedelics' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that AdvisorShares Psychedelics is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.| AdvisorShares Psychedelics generated a negative expected return over the last 90 days | |
| Latest headline from zacks.com: Best-Performing Active ETFs of 2025 | |
| The fund maintains 91.92% of its assets in stocks |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.